Pamela Scagliarini named COO of Bridgeport Hospital: 5 things to know

Pamela Scagliarini has been named COO of Bridgeport (Conn.) Hospital and senior vice president of Yale New Haven Health System in New Haven, Conn., according to a New Haven Register report.

Advertisement

Here are five things to know about Ms. Scagliarini.

1.  Ms. Scagliarini is replacing Norman G. Roth, who was recently named president of Greenwich (Conn.) Hospital and executive vice president of YNHHS.

2. Ms. Scagliarini has been with YNHHS for more than two decades.

3. Ms. Scagliarini started as a contract coordinator in the purchasing department at Yale-New Haven Hospital in New Haven, advancing to vice president of the system’s supply chain management division, and joined Bridgeport Hospital last September as interim senior vice president of operations.

4. “She has excelled in all facets of her role,” William M. Jennings, president and CEO of Bridgeport Hospital and executive vice president of YNHHS, said in a news release, according to the report. “Her resolute work ethic and solid personal values reflect those of our health system.”

5. Ms. Scagliarini earned a bachelor’s degree in procurement and materials management/operations management from the Bowling Green University in Ohio, and a Master of Business Administration in healthcare management from the University of New Haven. 

 

More stories on healthcare executive moves:

4-hospital Guthrie welcomes new CIO
13 latest hospital, health system CEO moves
6 months in: 395 executive moves to know

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.